AwardTape · Defense awards · Genovac Antibody Discovery LLC
Genovac Antibody Discovery LLC: $121K in DoD and DHS awards
Genovac Antibody Discovery LLC holds 2 DoD and DHS prime awards with $121K obligated Mar 27, 2024 to Apr 8, 2026. Largest category: Studies and analysis at $120K; largest buyer: Defense Health Agency at $121K.
| Obligated FY2024+ | $121K |
|---|---|
| Awards | 2 |
| FY2024 | $121K |
| FY2025 | $0 |
| FY2026 to date | $0 |
| Lifetime obligated on these awards | $205K |
| First and latest action | Mar 27, 2024 · Apr 8, 2026 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Studies and analysis | $120K | 1 awards | 99% |
| 2 | Health R&D | $1.0K | 1 awards | 0.8% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Defense Health Agency | $121K | 2 awards | 100% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| HT942524P0103 purchase order | $120K | Human monoclonal antibody development | Defense Health Agency | Studies and analysis | Apr 8, 2026 DoD 90d |
| HT942523P0030 purchase order | $1.0K | Generation of monoclonal antibodies | Defense Health Agency | Health R&D | Mar 27, 2024 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial